SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:1457 4969
 

Sökning: L773:1457 4969 > Molecular adsorbent...

  • Gilg, StefanKarolinska Institutet (författare)

Molecular adsorbent recirculating system treatment in patients with post-hepatectomy liver failure : Long-term results of a pilot study

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • 2022-08-24
  • SAGE Publications,2022
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-494760
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-494760URI
  • https://doi.org/10.1177/14574969221112224DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:150536883URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background: Post-hepatectomy liver failure (PHLF) is the leading cause of postoperative mortality following major liver resection. Between December 2012 and May 2015, 10 consecutive patients with PHLF (according to the Balzan criteria) following major/extended hepatectomy were included in a prospective treatment study with the molecular adsorbent recirculating system (MARS). Sixty- and 90-day mortality rates were 0% and 10%, respectively. Of the nine survivors, four still had liver dysfunction at 90 days postoperatively. One-year overall survival (OS) of the MARS-PHLF cohort was 50%. The present study aims to assess long-term outcome of this cohort compared to a historical control cohort.Methods: To compare long-term outcome of the MARS-PHLF treatment cohort with PHLF patients not treated with MARS, the present study includes all 655 patients who underwent major hepatectomy at Karolinska University Hospital between 2010 and 2018. Patients with PHLF were identified according to the Balzan criteria.Results: The cohort was split into three time periods: pre-MARS period (n = 192), MARS study period (n = 207), and post-MARS period (n = 256). The 90-day mortality of patients with PHLF was 55% (6/11) in the pre-MARS period, 14% during the MARS study period (2/14), and 50% (3/6) in the post-MARS period (p = 0.084). Median OS (95% confidence interval (CI)) was 37.8 months (29.3–51.7) in the pre-MARS cohort, 57 months (40.7–75.6) in the MARS cohort, and 38.8 months (31.4–51.2) in the post-MARS cohort. The 5-year OS of 10 patients included in the MARS study was 40% and the median survival 11.6 months (95% CI: 3 to not releasable). In contrast, for the remaining 21 patients fulfilling the Balzan criteria during the study period but not treated with MARS, the 5-year OS and median survival were 9.5% and 7.3 months (95% CI, 0.5–25.9), respectively (p = 0.138)).Conclusions: MARS treatment may contribute to improved outcome of patients with PHLF. Further studies are needed.The initial pilot study was registered at ClinicalTrials.gov (NCT03011424).

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Sparrelid, ErnestoKarolinska Institutet (författare)
  • Engstrand, JennieKarolinska Institutet (författare)
  • Baumgartner, RuthKarolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden. (författare)
  • Nowak, GregKarolinska Inst, Karolinska Univ Hosp, Dept Clin Sci, Stockholm, Sweden.;Karolinska Univ Hosp, Dept Transplantat Surg, Stockholm, Sweden. (författare)
  • Stal, PerKarolinska Institutet (författare)
  • D'Souza, MelroyKarolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden. (författare)
  • Jansson, AndersKarolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden. (författare)
  • Isaksson, BengtUppsala universitet,Gastrointestinalkirurgi(Swepub:uu)benis326 (författare)
  • Jonas, EduardUniv Cape Town, Fac Hlth Sci, Dept Surg, Cape Town, South Africa. (författare)
  • Stromberg, CeciliaKarolinska Institutet (författare)
  • Karolinska InstitutetKarolinska Inst, Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol CLINTEC, Div Surg, Stockholm, Sweden. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Scandinavian Journal of Surgery: SAGE Publications111:3, s. 48-551457-49691799-7267

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy